Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00186225 · ClinicalTrials.gov registry record · NA
Stem Cell Transplant From Matched Unrelated or Partially Matched Related Donors
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 250
- Enrollment target
NCT00186225: Completed NA study, sponsored by Stanford University.
NCT00186225 is a NA study that has completed, run by Stanford University. The registered enrollment target is 250 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00186225, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 250 participants
- Enrollment target
Study Summary
To evaluate the use of unrelated donors for hematopoietic cell transplantation in the treatment of hematologic and lymphoid malignancies.
Interventions
- PROCEDURE ablative allogeneic hematopoietic cell transplantation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 1989-11 |
| Est. Completion | 2010-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00186225
The ClinicalTrials.gov registry entry for NCT00186225 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ablative allogeneic hematopoietic cell transplantation is the first listed.
NCT00186225 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00186225 about?
NCT00186225 is a clinical study titled "Stem Cell Transplant From Matched Unrelated or Partially Matched Related Donors". To evaluate the use of unrelated donors for hematopoietic cell transplantation in the treatment of hematologic and lymphoid malignancies.
What is the current status of trial NCT00186225?
This trial is currently completed. It is a NA study. The enrollment target is 250 participants. The study started on 1989-11. Estimated completion is 2010-05.
What interventions are being tested in trial NCT00186225?
The interventions under investigation include: ablative allogeneic hematopoietic cell transplantation (PROCEDURE).
Who is sponsoring clinical trial NCT00186225?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.